The absence of RKIP as an independent prognostic marker highlights its potential application in treatment plans, as RKIP levels can be solely analyzed as an indicator of cancer metastasis without concerns of additional biomarkers interfering with the analysis. This evidence concerns the gene PEBP1 and cancer.